Search Results - "Tsoukas, C. M."

Predictors of unstructured antiretroviral treatment interruption and resumption among HIV‐positive individuals in Canada by Samji, H, Taha, TE, Moore, D, Burchell, AN, Cescon, A, Cooper, C, Raboud, JM, Klein, MB, Loutfy, MR, Machouf, N, Tsoukas, CM, Montaner, JSG, Hogg, RS, Aykroyd, G, Balfour, L, Bayoumi, A, Burchell, A, Cairney, J, Calzavara, L, Cescon, A, Cooper, C, Gough, K, Guillemi, S, Harrigan, PR, Harris, M, Hatzakis, G, Hogg, R, Hosein, S, Kilby, D, Klein, M, Lalonde, R, Lima, V, Loutfy, M, Machouf, N, Mills, E, Millson, P, Montaner, J, Moore, D, Palmer, A, Raboud, J, Rachlis, A, Read, S, Rourke, S, Samji, H, Smieja, M, Salit, I, Taylor, D, Trottier, B, Tsoukas, C, Walmsley, S, Wobeser, W, Fisher, M, Gardner, S, Gataric, N, Colley, G, Rueda, S, Yip, B

“…Objectives Sustained optimal use of combination antiretroviral therapy (cART) has been shown to decrease morbidity, mortality and HIV transmission. However,…”
Get full text

Hepatitis C Virus Is Related to Progressive Liver Disease in Human Immunodeficiency Virus—Positive Hemophiliacs and Should Be Treated as an Opportunistic Infection by Lesens, Olivier, Deschênes, Marc, Steben, Marc, Bélanger, Gisèle, Tsoukas, Christos M.

“…The hypothesis was investigated that hepatitis C virus (HCV) infection behaves like an opportunistic infection in which progressive liver disease (PLD) is the…”
Get full text

Indinavir crystalluria by Gagnon, R.F., Alli, A.I., Watters, A.K., Tsoukas, C.M.

Get full text

Markers predicting progression of human immunodeficiency virus-related disease by TSOUKAS, C. M, BERNARD, N. F

“…Classifications Services CMR Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Human Immunodeficiency Virus (HIV)—Specific Cytotoxic T Lymphocyte Activity in HIV-Exposed Seronegative Persons by Bernard, Nicole F., Yannakis, Christina M., Lee, Jimmy S., Tsoukas, Christos M.

“…Repeated exposure to human immunodeficiency virus (HIV) does not always result in seroconversion. Understanding the conditions that permit or protect against…”
Get full text

Prospective study of urinalysis abnormalities in HIV-positive individuals treated with indinavir by Gagnon, Raymonde F., Tecimer, Sandy N., Watters, Andrew K., Tsoukas, Christos M.

“…Indinavir is a potent protease inhibitor widely used in combination with reverse-transcriptase inhibitors to treat human immunodeficiency virus (HIV) disease…”
Get full text

Low urine pH is associated with reduced indinavir crystalluria in indinavir-treated HIV-infected individuals by Gagnon, R F, Alli, A I, Edwardes, M D, Watters, A K, Tsoukas, C M

“…Indinavir is a potent HIV-1 protease inhibitor included in current antiretroviral therapeutic regimens. It is associated with renal and urological…”
Get more information

Genotype and phenotype of cytochrome P450 2D6 in human immunodeficiency virus-positive patients and patients with acquired immunodeficiency syndrome by O'NEIL, W. M, GILFIX, B. M, MARKOGLOU, N, DI GIROLAMO, A, TSOUKAS, C. M, WAINER, I. W

“…To examine the distribution of the cytochrome P450 (CYP) CYP2D6 phenotype and its relation to genotype, concomitant medication, and disease state in human…”
Get full text

A density functional study of the hydrogen-bond network within the HIV-1 protease catalytic site cleft by Sirois, S., Proynov, E. I., Truchon, J.-F., Tsoukas, C. M., Salahub, D. R.

“…The relative energy between two different protonation sites of the Asp25′ catalytic site residue is computed and analyzed for various HIV‐1 Protease/inhibitor…”
Get full text

Activity of the soft gelatin formulation of saquinavir in combination therapy in antiretroviral-naive patients by MITSUYASU, R. T, SKOLNIK, P. R, TORRES, R. A, TSOUKAS, C. M, COHEN, S. R, CONWAY, B, GILL, M. J, JENSEN, P. C, PULVIRENTI, J. J, SLATER, L. N, SCHOOLEY, R. T, THOMPSON, M. A

“…Objective: A Phase II, open-label, randomized, parallel-arm, multicentre trial to compare the antiviral activity and safety of two formulations of saquinavir…”
Get full text

Glucuronidation and sulphation of paracetamol in HIV‐positive patients and patients with AIDS by O'NELL, W. M, PEZZULLO, J. C, DI GIROLAMO, A, TSOUKAS, C. M, WAINER, I. W

“…Aims To gauge the effect of disease state and disease progression on the glucuronidation and sulphation of paracetamol (APAP) among HIV‐positive patients and…”
Get full text

N‐acetylation among HIV‐positive patients and patients with AIDS: When is fast, fast and slow, slow? by O'Neil, William M., Gilfix, Brian M., DiGirolamo, Antonietta, Tsoukas, Christos M., Wainer, Irving W.

“…Background The discrepancy between genotype and expressed phenotype of the polymorphic N‐acetyltransferase (NAT2) has been suggested by separate genotypic and…”
Get full text

Light microscopy of indinavir urinary crystals by Gagnon, R F, Tsoukas, C M, Watters, A K

Get full text

HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected persons by BERNARD, N. F, PEDERSON, K, CHUNG, F, OUELLET, L, WAINBERG, M. A, TSOUKAS, C. M

“…CD8+ T-cell counts usually increase soon after infection with HIV, whereas CD4+ cell counts decrease. The result of these changes in T-cell subpopulation…”
Get full text

Active immunization of patients with HIV infection: a study of the effect of VaxSyn, a recombinant HIV envelope subunit vaccine, on progression of immunodeficiency by Tsoukas, C M, Raboud, J, Bernard, N F, Montaner, J S, Gill, M J, Rachlis, A, Fong, I W, Schlech, W, Djurdjev, O, Freedman, J, Thomas, R, Lafrenière, R, Wainberg, M A, Cassol, S, O'Shaughnessy, M, Todd, J, Volvovitz, F, Smith, G E

“…Infection with the human immunodeficiency virus (HIV) leads to a progressive immunodeficiency characterized by decreasing levels of CD4+ T lymphocytes. VaxSyn,…”
Get more information

A Comparison of Two Regimens for the Treatment of Mycobacterium avium Complex Bacteremia in AIDS: Rifabutin, Ethambutol, and Clarithromycin versus Rifampin, Ethambutol, Clofazimine, and Ciprofloxacin by Shafran, Stephen D, Singer, Joel, Zarowny, Donald P, Phillips, Peter, Salit, Irving, Walmsley, Sharon L, Fong, Ignatius W, Gill, M. John, Rachlis, Anita R, Lalonde, Richard G, Fanning, Mary M, Tsoukas, Christos M

“…Disseminated Mycobacterium avium complex infection is the most common opportunistic bacterial infection in adults infected with the human immunodeficiency…”
Get full text

A phase I study of letrazuril in AIDS-related cryptosporidiosis by Harris, M, Deutsch, G, MacLean, J D, Tsoukas, C M

“…The intestinal parasite Cryptosporidium is a common cause of chronic diarrhoea in AIDS patients and is responsible for significant morbidity and mortality. No…”
Get more information

Are the KIR3DS1homozygous and KIR3DL1h/y+HLA-B57 genotypes associated protection from HIV by different routes of exposure? by Tallon, B, Bruneau, J, Tsoukas, CM, Routy, J, Bernard, NF

“…Doc number: P186…”
Get full text

Comparison of HIV-specific CD8 T-cell responses among uninfected individuals exposed to HIV parenterally and mucosally by Makedonas, George, Bruneau, Julie, Alary, Michel, Tsoukas, Christos M, Lowndes, Catherine M, Lamothe, François, Bernard, Nicole F

“…To assess the influence of route of HIV exposure on the development of HIV-specific CD8 T-cell responses in exposed, uninfected (EU) individuals. Two groups of…”
Get full text

Longitudinal Assessment of Changes in HIV-Specific Effector Activity in HIV-Infected Patients Starting Highly Active Antiretroviral Therapy in Primary Infection by Alter, Galit, Hatzakis, George, Tsoukas, Christos Micheal, Pelley, Karen, Rouleau, Danielle, LeBlanc, Roger, Baril, Jean-Guy, Dion, Harold, Lefebvre, Eric, Thomas, Rejean, Cote, Pierre, Lapointe, Normand, Routy, Jean-Pierre, Sekaly, Rafik-Pierre, Conway, Brian, Bernard, Nicole Flore

“…Both the magnitude and breadth of HIV-specific immunity were evaluated longitudinally on samples collected from six subjects starting highly active…”
Get full text